- Antiamnesic use of pteridine derivatives
-
Pteridines of general formula (I): STR1 in which Y and Z, which can be identical or different, are hydrogen, OH or NH2, and X1 and X2, which can be identical or different, are hydrogen, OH, C1 -C4 alkyl, phenyl, hydroxymethyl or carboxyl, for the preparation of pharmaceutical compositions for treating cognitive pathologies characterized by memory and vigilance disturbances, such as senile dementia of Alzheimer type, multiinfarctual dementia, metabolic encephalopathies, Korsakoff's syndrome, and the consequences of the abuse of certain therapies such as anxiolytic and neuroleptic.
- -
-
-
- Pteridines suitable for the preparation of pharmaceutical compositions with antiamnesic activity
-
Pteridines of general formula (I): in which Y and Z, which can be identical or different, are hydrogen, OH or NH2, and X1 and X2, which can be identical or different, are hydrogen, OH, C1-C4 alkyl, phenyl, hydroxymethyl or carboxyl, for the preparation of pharmaceutical compositions for treating cognitive pathologies characterised by memory and vigilance disturbances, such as senile dementia of Alzheimer type, multiinfarctual dementia, metabolic encephalopathies, Korsakoff's syndrome, and the consequences of the abuse of certain therapies such as anxiolytic and neuroleptic.
- -
-
-